Related Experiment Video
Updated: Jul 26, 2025

09:51
Establishment of Genome-edited Human Pluripotent Stem Cell Lines: From Targeting to Isolation
Published on: February 2, 2016
13.7K
Gene editing with 'pencil' rather than 'scissors' in human pluripotent stem cells
Ju-Chan Park1, Mihn Jeong Park1, Seung-Yeon Lee1
1College of Pharmacy, Seoul National University, 1 Gwanak-ro, Gwanak-gu, 08826, Seoul, Republic of Korea.
Stem Cell Research & Therapy
|June 20, 2023
Summary
Advances in genome editing enable precise DNA changes in human pluripotent stem cells (hPSCs). This facilitates creating disease models and developing cell therapies by correcting mutations.
Area of Science:
- Stem Cell Biology
- Genetics
- Molecular Biology
Background:
- Genome editing technologies have advanced significantly.
- Human pluripotent stem cells (hPSCs) are crucial for disease modeling and cell therapy.
- Pathogenic variants often involve point mutations.
Purpose of the Study:
- To review recent progress in genome editing methodologies.
- To highlight the application of hPSCs in translational medicine.
- To discuss the development of novel gene editing tools.
Main Methods:
- Review of current literature on genome editing techniques.
- Focus on base editing and prime editing tools.
- Discussion of homologous directed repair (HDR) strategies.
- Analysis of Cas9 endonuclease applications.
Main Results:
- Development of precise gene editing tools beyond traditional CRISPR-Cas9.
- Successful creation of isogenic disease models using hPSCs.
- Potential for autologous cell therapy through gene correction in hPSCs.
- Avoidance of off-target mutations and large deletions with new editing methods.
Conclusions:
- Genome editing in hPSCs offers powerful approaches for understanding diseases.
- Novel 'pencil-like' gene editing tools provide greater precision.
- These advancements pave the way for future clinical applications in cell therapy.
Related Concept Videos
Induced Pluripotent Stem Cells
24.3K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
24.3K
Chromatin Modification in iPS Cells
1.7K
Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
1.7K

